umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
EGFR gene variants are associated with specific somatic aberrations in glioma
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Patologi.
Visa övriga samt affilieringar
2012 (Engelska)Ingår i: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 7, nr 12, s. e47929-Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

A number of gene variants have been associated with an increased risk of developing glioma. We hypothesized that the reported risk variants may be associated with tumor genomic instability. To explore potential correlations between germline risk variants and somatic genetic events, we analyzed matched tumor and blood samples from 95 glioma patients by means of SNP genotyping. The generated genotype data was used to calculate genome-wide allele-specific copy number profiles of the tumor samples. We compared the copy number profiles across samples and found two EGFR gene variants (rs17172430 and rs11979158) that were associated with homozygous deletion at the CDKN2A/B locus. One of the EGFR variants (rs17172430) was also associated with loss of heterozygosity at the EGFR locus. Our findings were confirmed in a separate dataset consisting of matched blood and tumor samples from 300 glioblastoma patients, compiled from publically available TCGA data. These results imply there is a functional effect of germline EGFR variants on tumor progression.

Ort, förlag, år, upplaga, sidor
plosone.org , 2012. Vol. 7, nr 12, s. e47929-
Nationell ämneskategori
Medicinsk genetik Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:umu:diva-62754DOI: 10.1371/journal.pone.0047929PubMedID: 23236348OAI: oai:DiVA.org:umu-62754DiVA, id: diva2:577944
Tillgänglig från: 2012-12-20 Skapad: 2012-12-17 Senast uppdaterad: 2018-06-08Bibliografiskt granskad
Ingår i avhandling
1. Genotype-phenotype studies in brain tumors
Öppna denna publikation i ny flik eller fönster >>Genotype-phenotype studies in brain tumors
2013 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Meningioma and glioma are the most common primary brain tumors, but their etiologies are largely unknown. Although meningioma is usually benign, their intracranial location can lead to lethal consequences, and despite progress in surgery, radiotherapy, and chemotherapy the prognosis for patients with glioma remains poor. The only well-established environmental risk factor for meningioma and glioma is ionizing radiation. Evidence for inherited predisposition to meningioma and glioma is provided by a number of rare inherited syndromes where collectively these diseases account for only a small proportion of the twofold increased risk of brain tumors seen in first-degree relatives for meningioma and glioma patients. It is very possible that much of the excess familial risk is a consequence of co-inheritance of multiple low-risk genetic variations. With this in mind, the aims of the studies in this thesis were to discover genetic risk variants influencing the probability of acquiring the disease and to identify the association between risk variants on the tumor phenotype.

To identify genetic variants influencing meningioma risk, a comprehensive tagging of the selected genes in a case-control study was performed. We identified nine risk variants in

EGF, ERBB2, and LRIG2 genes. However, these findings could not be confirmed in another larger independent dataset. In addition, the study identified a correlation between LRIG2 protein expression and ER status when analyzed with different parameters. In a separate study with a larger sample of meningioma patients, the same correlation between LRIG2 and ER status was observed.

To explore the potential association between reported germline risk variants and somatic genetic events, matched tumor and blood samples from glioma patients were analyzed by SNP array. The results identified correlations between

EGFR gene variants and somatic aberrations within the EGFR locus and CDKN2A/B locus. To further study the relationship between germline risk variants and tumor phenotype, the same patient material was used and analyzed by three different techniques: SNP array, IHC, and FISH. The results revealed EGFR risk variants effecting copy number variation of the EGFR gene and the expression of the IDH1 and p53. Further comparison between different techniques such as SNP array and FISH analysis revealed the difficulty in achieving consistent results with different techniques.

To summarize, the glioma studies show a link between genotype and phenotype where genetic risk variants in the

EGFR gene were found to be associated with specific somatic aberrations. These associations are biologically interesting because EGFR is involved in multiple cellular processes. Additional studies of the direct functional role of these observations need to be conducted to elucidate the molecular mechanisms underlying the identified association between germline gene variants and somatic aberrations. For the meningioma studies, no significant risk variants influencing the disease were found but a correlation between LRIG2 and ER status was observed. This result suggests a potential role for the LRIG protein in the pathogenesis of meningioma, but more studies are needed to confirm this hypothesizes.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå Universitet, 2013. s. 64
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1657
Nyckelord
Glioma, Meningioma, SNP, IHC, FISH, LRIG2, EGF, EGFR, ERBB2, ER, CDKN2A/B, IDH1
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
onkologi
Identifikatorer
urn:nbn:se:umu:diva-83185 (URN)978-91-7459-754-7 (ISBN)
Disputation
2013-12-12, Betula, by 6M, Norrlands universitetssjukhus, Umeå, 09:00 (Engelska)
Opponent
Handledare
Anmärkning

Cancer research foundation in northern Sweden and Lions cancer research foundation at Umeå university

Tillgänglig från: 2013-11-21 Skapad: 2013-11-20 Senast uppdaterad: 2018-06-08Bibliografiskt granskad

Open Access i DiVA

EGFR gene variants are associated with specific somatic aberrations in glioma(785 kB)375 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 785 kBChecksumma SHA-512
fb410cb77eaec908bf4f2ecdea056ee1d359592929eb25bf8cc735fcd0b43733f57e5025af27b9efb12614584c8ecc695c05fe771276877790c7f31f8e8ca210
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Wibom, CarlGhasimi, SomaBrännström, ThomasTrygg, JohanHenriksson, RogerBergenheim, TommyAndersson, UlrikaRydén, PatrikMelin, Beatrice

Sök vidare i DiVA

Av författaren/redaktören
Wibom, CarlGhasimi, SomaBrännström, ThomasTrygg, JohanHenriksson, RogerBergenheim, TommyAndersson, UlrikaRydén, PatrikMelin, Beatrice
Av organisationen
OnkologiPatologiKemiska institutionenKlinisk neurovetenskapInstitutionen för matematik och matematisk statistik
I samma tidskrift
PLoS ONE
Medicinsk genetikCancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 375 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 439 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf